Log in to save to my catalogue

MECOM promotes leukemia progression and inhibits mast cell differentiation through functional compet...

MECOM promotes leukemia progression and inhibits mast cell differentiation through functional compet...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_biorxiv_primary_2024_05_20_594903

MECOM promotes leukemia progression and inhibits mast cell differentiation through functional competition with GATA2

About this item

Full title

MECOM promotes leukemia progression and inhibits mast cell differentiation through functional competition with GATA2

Publisher

Cold Spring Harbor Laboratory

Journal title

bioRxiv, 2024-05

Language

English

Formats

Publication information

Publisher

Cold Spring Harbor Laboratory

Subjects

Subjects and topics

More information

Scope and Contents

Contents

MECOM is a nuclear transcription factor essential for the proliferation of hematopoietic stem cells (HSCs) and myeloid leukemia cells. MECOM contains N- and C-terminal zinc finger domains (ZFDs) and binding motifs for the corepressor CtBP to regulate gene expression. Recent studies have shown that germline MECOM variants are associated with thrombo...

Alternative Titles

Full title

MECOM promotes leukemia progression and inhibits mast cell differentiation through functional competition with GATA2

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_biorxiv_primary_2024_05_20_594903

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_biorxiv_primary_2024_05_20_594903

Other Identifiers

E-ISSN

2692-8205

DOI

10.1101/2024.05.20.594903

How to access this item